BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 315807)

  • 1. Circulating breast tumour antigen-sensitive T lymphocytes in early breast cancer and high risk benign breast disease.
    Ramey WG; Hashim GA; Fitzpatrick HF
    Br J Surg; 1979 Dec; 66(12):848-52. PubMed ID: 315807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, stage, and prognosis of lung carcinoma by preoperative assay of lung tumor antigen-sensitive T lymphocytes.
    Ramey WG; Fitzpatrick HF; Hashim GA; Munther AS; Swistel AJ; Burrows WB
    J Thorac Cardiovasc Surg; 1980 Nov; 80(5):656-60. PubMed ID: 6968856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of breast tumor antigen-sensitive circulating T-lymphocytes by antigen-stimulated active rosette formation.
    Ramey WG; Hashim GA; Burrows WB; Swistel AJ; Munther A; Fitzpatrick HF
    Cancer Res; 1979 Dec; 39(12):4796-801. PubMed ID: 315272
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of circulating lung tumor antigen-sensitive T lymphocytes in the early stages of lung cancer.
    Ramey WG; Hashim GA; Munther AS; Swistel AJ; Burrows WB; Fitzpatrick HF
    Surgery; 1980 Aug; 88(2):202-7. PubMed ID: 6967233
    [No Abstract]   [Full Text] [Related]  

  • 5. [B cells and serum immunoglobulins in patients with breast pathology].
    Zornoza G; Hernández JL; Sanz ML; Fernández J; Goena I; Lera JM
    Rev Esp Oncol; 1981; 28(1):17-27. PubMed ID: 6984973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disorders of the immune system in benign lesions and cancer of the breast].
    Derevnina NA; Polevaia EB; Veskova TK; Trubcheninova LP; Bogatyrev VN
    Vopr Onkol; 1989; 35(7):810-6. PubMed ID: 2788960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular antitumor immune response in women with risk factors for breast cancer.
    Sanner T; Brennhovd I; Christensen I; Jørgensen O; Kvaløy S
    Cancer Res; 1979 Feb; 39(2 Pt 2):654-7. PubMed ID: 761231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extension of the rosette test in the estimation of TAA-binding cells in breast cancer and mastopathy patients].
    Sauer H; Preusse C; Gläser A; Hädge D; Kraus I; Ambrosius H
    Allerg Immunol (Leipz); 1982; 28(3):177-86. PubMed ID: 6183964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypotheses on the tumoral nature of fibrocystic mastopathy. Review of bibliographic data and experimental immunologic tests].
    Cavallini G
    Minerva Med; 1982 Sep; 73(34):2147-55. PubMed ID: 7110597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin basic protein-stimulated rosette-forming T cells in multiple sclerosis.
    Hashim GA; Lee DH; Pierce JC; Braun CW; Fitzpatrick
    Neurochem Res; 1978 Feb; 3(1):37-48. PubMed ID: 79987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sera from breast cancer patients contain an IgA antibody to a breast cyst fluid component.
    Witkin SS; Richards JM; Bongiovanni AM; Breed CN; Day NK
    Clin Immunol Immunopathol; 1982 May; 23(2):358-65. PubMed ID: 6286196
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal antibody B72.3 in benign breast lesions.
    Soomro S; Shousha S
    J Clin Pathol; 1990 Dec; 43(12):1026-8. PubMed ID: 2266175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
    Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of mammary serum antigen assay in the management of breast cancer: a preliminary report.
    Tjandra JJ; Russell IS; Collins JP; Stacker SA; McKenzie IF
    Br J Surg; 1988 Aug; 75(8):811-7. PubMed ID: 3048535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity of non-specific T-suppressors regulating the proliferation of B- and T-lymphocytes in patients with fibroadenomatosis, breast cancer and stomach cancer].
    Grinevich IuA; Drannik GN; Nikol'skiĭ IS; Kalinina NA; Litvishchenko EI
    Vopr Onkol; 1984; 30(12):23-7. PubMed ID: 6240157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Search for the heterogenetic Forssman antigen in human breast tumor tissue].
    Berdinskikh MS; Pavliuchenkova RP; Kiseleva AS; Kulakova AM; Kosiakov PN
    Biull Eksp Biol Med; 1981 Dec; 92(12):710-1. PubMed ID: 7326421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An immunohistologic study of reactive lymphocytes in breast tissue].
    Oyamada S; Oyama H; Tokunaga M
    Gan No Rinsho; 1988 Oct; 34(12):1685-9. PubMed ID: 2461454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiparametric observation of immune competence in breast cancer and its correlation with tumour load and prognosis.
    Das SN; Khanna NN; Khanna S
    Ann Acad Med Singap; 1985 Apr; 14(2):374-81. PubMed ID: 3876055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay.
    Cannon GB; McCoy JL; Jerome LJ; Reddick R; Alford C; Tinley V; Herberman RB
    J Natl Cancer Inst; 1978 Nov; 61(5):1181-6. PubMed ID: 280705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics of T lymphocyte subpopulations in guinea-pigs sensitized with allogeneic transplantation antigens.
    Hashim GA; Yee N; Ramey WG
    Clin Exp Immunol; 1980 Sep; 41(3):533-40. PubMed ID: 6969158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.